Alex Pearson

7PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Iseult M Browne, Javier Pascual, Rosalind J Cutts

|Nov 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer.

Belinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu

|Sep 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).

Alistair Ring, Lucy S Kilburn, Alex Pearson

|Oct 18, 2019
Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.

Rina Hui, Alex Pearson, Javier Cortes

Pageof 2